Tag: large volume parenteral (lvp) market

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Influenza Vaccines Industry In 2025?

The influenza vaccines market has experienced substantial growth in recent years. It is forecast to grow from $8.5 billion in 2024 to $9.04 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.3%. The growth observed in the past can be attributed to elements such as pandemic preparedness, various public health initiatives, studies on vaccine effectiveness, advice from healthcare professionals, and global influenza surveillance efforts.

The influenza vaccines market is projected to experience substantial expansion over the upcoming years. By 2029, its valuation is anticipated to reach $12.13 billion, progressing at a compound annual growth rate (CAGR) of 7.6%. This anticipated expansion during the forecast period is driven by various factors, including climate and environmental considerations, enhanced healthcare accessibility, the emergence of novel influenza strains, advancements in adjuvants and delivery systems, and increasing healthcare spending. Key developments expected throughout this period encompass the broader adoption of mRNA vaccine technology, an increased emphasis on pediatric immunization, the implementation of seasonal influenza control measures, improved vaccination coverage in developing countries, and the development of customized vaccination approaches.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Influenza Vaccines Industry?

The rising incidences of seasonal influenza are expected to propel the growth of the influenza vaccine market going forward. Seasonal influenza refers to a respiratory illness caused by influenza viruses that typically circulate and cause infections during specific times of the year, usually in the colder months. This increased occurrence has resulted from antigenic drift, population susceptibility, environmental factors, incomplete vaccine coverage, and a lack of universal vaccination. Influenza vaccines help in reducing the incidences of seasonal influenza by providing immunization against the circulating strains of the virus. For example, in November 2023, the Centers for Disease Control and Prevention (CDC) reported that during the 2022-2023 flu season, there were approximately 31 million flu-related illnesses, 14 million flu-related medical visits, 360,000 flu-related hospitalizations, and 21,000 flu-related deaths. Therefore, the rising incidences of seasonal influenza are driving the growth of the influenza vaccines market.

How Is The Influenza Vaccines Market Classified Into Different Segments?

The influenza vaccines market covered in this report is segmented –

1) By Vaccine Type: Inactivated, Live Attenuated

2) By Valency: Quadrivalent, Trivalent

3) By Route Of Administration: Injection, Nasal Spray

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:

1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)

2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

Which Competitive Trends Are Defining The Influenza Vaccines Market Structure?

The influenza vaccine market is increasingly characterized by technologically advanced vaccine production, emerging as a significant area of focus. Companies operating in this sector are employing sophisticated vaccine manufacturing technologies to maintain their market presence. Illustratively, GlaxoSmithKline PLC., a UK-based pharmaceutical and biotechnology company, launched MAPS – Multiple Antigen Presenting System for vaccine development in January 2023. This technology offers an innovative approach to creating effective vaccines to combat bacteria and viruses, proving particularly beneficial for developing vaccines rapidly during an epidemic or pandemic outbreak.

Who Are The Prominent Global Companies Shaping The Influenza Vaccines Market?

Major companies operating in the influenza vaccines market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, Gamma Vaccines Pty. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

How Do Regional Market Performances Compare Within The Influenza Vaccines Industry?

North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Influenza Vaccines Market Report:

https://www.thebusinessresearchcompany.com/customise?id=11935&type=smp

Browse Through More Reports Similar to the Global Influenza Vaccines Market 2025, By The Business Research Company

Iot In Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

Power Generators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/power-generators-global-market-report

Ventricular Assist Device Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Influenza Vaccines Market Valued at Present and by 2029?

In recent times, the influenza vaccines market size has seen robust growth. The market, which is set to expand from $8.5 billion in 2024 to $9.04 billion in 2025, will have a compound annual growth rate (CAGR) of 6.3%. A few contributing factors to this growth during the historic period have been the readiness for pandemics, initiatives in public health, studies on the effectiveness of vaccines, recommendations from healthcare professionals, and worldwide surveillance of influenza.

Strong expansion is anticipated in the influenza vaccines market in the upcoming years. The market is predicted to ascend to “$12.13 billion in 2029, experiencing a compound annual growth rate (CAGR) of 7.6%. The projected growth during this period can be ascribed to factors such as climate and environmental changes, enhancements in healthcare accessibility, the emergence of new influenza strains, adjuvants and delivery systems innovations, and an increase in healthcare spending. Forecast trends include the broader application of mRNA vaccine technology, a concentration on pediatric immunization, measures to control seasonal influenza, improved vaccination coverage in underdeveloped countries, and custom vaccination strategies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

#What Drivers Are Influencing Growth In The Influenza Vaccines Market?

The influenza vaccine market’s expansion is anticipated to be spurred by increasing occurrences of seasonal influenza. This respiratory illness, typically rampant during certain periods of the year, especially the colder months, is brought about by influenza viruses. The emergence of this shift can be attributed to antigenic drift, environmental factors, population vulnerability, suboptimal vaccine coverage, and an absence of universal vaccination. Influenza vaccines play a crucial role in decreasing the incidents of seasonal influenza by providing immunity against the active strains of the virus. For instance, the US government agency, the Centers for Disease Control and Prevention (CDC), in November 2023, revealed that there were roughly 31 million instances of flu-related illnesses, 14 million flu-related clinical visits, 360,000 flu-related hospital stays, and 21,000 flu-related fatalities during the 2022-2023 flu season. Consequently, the escalating occurrences of influenza seasons are fuelling the growth of the influenza vaccines market.

The influenza vaccines market covered in this report is segmented –

1) By Vaccine Type: Inactivated, Live Attenuated

2) By Valency: Quadrivalent, Trivalent

3) By Route Of Administration: Injection, Nasal Spray

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:

1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)

2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

What Trends Are Currently Influencing Growth In The Influenza Vaccines Market?

The growing trend of utilizing cutting-edge technologies for vaccine production has been observed in the influenza vaccine market. To maintain their market stance, firms involved in influenza vaccine production are embracing these advanced manufacturing techniques. Take for example GlaxoSmithKline PLC., a pharmaceutical and biotechnology firm based in the UK, which initiated the Multiple Antigen Presenting System (MAPS) for vaccine creation in January 2023. This pioneering technique offers a new approach to build potent vaccines against bacteria and viruses. It can be particularly effective for swift vaccine development during outbreaks of epidemics or pandemics.

Which Companies Play A Key Role In The Development Of The Influenza Vaccines Market?

Major companies operating in the influenza vaccines market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, Gamma Vaccines Pty. Ltd.

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

What Are The Key Regional Developments Shaping The Influenza Vaccines Market?

North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11935&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Influenza Vaccines Market Heading Into 2029?

The market size for influenza vaccines has seen substantial growth in the previous years. The market is expected to escalate from $8.5 billion in 2024 to a whopping $9.04 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. The noticeable growth during the historic period can be credited to the need for pandemic preparedness, initiatives taken for public health, studies on the effectiveness of the vaccine, recommendations from healthcare professionals, and monitoring of global influenza.

The market for influenza vaccines is projected to experience substantial expansion in the coming years. It’s predicted to reach $12.13 billion by 2029, with a compound annual growth rate (CAGR) of 7.6%. This surge within the forecast timeframe is due to a combination of factors such as environmental and climate variables, enhanced healthcare access, the introduction of new influenza variants, innovations in adjuvants and delivery systems, and increased healthcare spending. Key trends predicted in the forecast period include an increased adoption of mRNA vaccine technology, a focus on pediatric immunization, measures to control seasonal influenza, improved vaccination outreach in developing countries, and customized vaccination strategies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

Which Factors Are Pushing The Influenza Vaccines Market Forward?

The increasing prevalence of seasonally occurring flu is anticipated to drive the influenza vaccine market’s expansion. Seasonal influenza is a respiratory illness triggered by influenza viruses, normally circulating and leading to infections at certain periods, particularly during colder months. Antigenic drift, population vulnerability, environmental factors, insufficient vaccine coverage, and the absence of universal vaccination have all contributed to this change. Influenza vaccines aid in diminishing seasonal flu incidences by providing immunity against the virus strains in circulation. For instance, the US government department, the Centers for Disease Control and Prevention (CDC), indicated in November 2023 that during the flu season of 2022-2023, there were roughly 31 million flu-related illnesses, 14 million medical visits due to flu, 360,000 hospitalizations related to flu, and 21,000 deaths caused by flu. Hence, the escalating prevalence of influenza seasons is fueling the growth of the market for influenza vaccines.

Which Segment Held The Largest Share In The Influenza Vaccines Market In 2025?

The influenza vaccines market covered in this report is segmented –

1) By Vaccine Type: Inactivated, Live Attenuated

2) By Valency: Quadrivalent, Trivalent

3) By Route Of Administration: Injection, Nasal Spray

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:

1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)

2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

How Are Key Trends Driving Expansion In The Influenza Vaccines Industry?

The usage of high-tech vaccine production has become a significant trend in the influenza vaccine market. To maintain their market foothold, firms in this sector are switching to cutting-edge vaccine production techniques. For example, GlaxoSmithKline PLC., a pharmaceutical and biotech company based in the UK, in January 2023, unveiled MAPS, or Multiple Antigen Presenting System, for the creation of vaccines. This innovative method offers a new approach to producing effective vaccines against bacteria and viruses. Moreover, this technology can be utilized to rapidly develop vaccines in the event of an epidemic or pandemic outbreak.

Which Organizations Are Driving Progress In The Influenza Vaccines Industry?

Major companies operating in the influenza vaccines market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, Gamma Vaccines Pty. Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Influenza Vaccines Industry?

North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11935&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Influenza Vaccines Market Growth in 2025?

The market size of influenza vaccines has experienced robust growth lately. It’s projected to expand from $7.35 billion in 2024 to $7.9 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The previous growth can be traced back to readiness for a pandemic, public health campaigns, effectiveness research for vaccines, recommendations from healthcare professionals, and worldwide influenza surveillance.

What Is the Forecast for the Influenza Vaccines Market Size Through 2029?

In the coming years, the influenza vaccines market is projected to experience robust growth. The market size is forecasted to reach $11.02 billion by 2029, with a compound annual growth rate (CAGR) of 8.7%. This growth during the estimated period is likely due to factors such as changes in climate and environment, betterment in healthcare accessibility, emergence of novel influenza variants, advancements in adjuvants and delivery systems, and an increase in healthcare spending. The forecast period may see a rise in trends such as the broader application of mrna vaccine technology, concentrated efforts on pediatric immunizations, measures to control seasonal influenza, improved vaccination rates in developing countries, and customized vaccination approaches.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

What are the Key Market Players in Influenza Vaccines Market and How They’re Evolving?

Major companies operating in the influenza vaccines market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, Gamma Vaccines Pty. Ltd.

What Are the Primary Growth Drivers in the Influenza Vaccines Market?

The growth of the influenza vaccine market is anticipated to be driven by an increase in cases of seasonal flu. Seasonal influenza, a respiratory illness caused by influenza viruses, usually occurs at specific times of the year, mostly during colder months. This trend is attributed to a combination of factors including antigenic drift, susceptibility among the population, environmental conditions, insufficient vaccine distribution, and the absence of all-encompassing vaccination. Influenza vaccines play a crucial role in decreasing instances of seasonal flu by offering immunity against the prevalent virus strains. For instance, in November 2023, the US government agency, the Centers for Disease Control and Prevention (CDC), reported roughly 31 million cases of flu-related illnesses, 14 million associated medical visits, 360,000 hospitalizations due to the flu, and 21,000 flu-related deaths during the 2022-2023 flu season. Hence, the escalating occurrence of influenza seasons is fueling the expansion of the influenza vaccines market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11935&type=smp

What Are the Leading Segments in the Global Influenza Vaccines Industry?

The influenza vaccines market covered in this report is segmented –

1) By Vaccine Type: Inactivated, Live Attenuated

2) By Valency: Quadrivalent, Trivalent

3) By Route Of Administration: Injection, Nasal Spray

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:

1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)

2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

What Are the Key Market Trends in the Influenza Vaccines Industry?

The rise in sophisticated vaccine production technology is becoming a pivotal trend in the influenza vaccine industry. Businesses in this sector are increasingly leveraging these advanced processes to maintain their market stance. For example, GlaxoSmithKline PLC., a British pharmaceutical and biotech firm, rolled out a Multi Antigen Presenting System (MAPS) for vaccine creation in January 2023. This cutting-edge approach offers a fresh perspective on generating potent vaccines against bacterial and viral threats. Importantly, this technology accelerates the development of vaccines, proving essential in the event of an epidemic or pandemic outbreak.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

What Is the Regional Outlook for the Influenza Vaccines Market?

North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11935

This Report Delivers Insight On:

1. How big is the influenza vaccines market, and how is it changing globally?

2. Who are the major companies in the influenza vaccines market, and how are they performing?

3. What are the key opportunities and risks in the influenza vaccines market right now?

4. Which products or customer segments are growing the most in the influenza vaccines market?

5. What factors are helping or slowing down the growth of the influenza vaccines market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the influenza vaccines industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Anticipated CAGR of the Influenza Vaccines Market, and What Factors Will Drive It?

The market size of influenza vaccines has experienced robust growth lately. It’s projected to expand from $7.35 billion in 2024 to $7.9 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The previous growth can be traced back to readiness for a pandemic, public health campaigns, effectiveness research for vaccines, recommendations from healthcare professionals, and worldwide influenza surveillance.

In the coming years, the influenza vaccines market is projected to experience robust growth. The market size is forecasted to reach $11.02 billion by 2029, with a compound annual growth rate (CAGR) of 8.7%. This growth during the estimated period is likely due to factors such as changes in climate and environment, betterment in healthcare accessibility, emergence of novel influenza variants, advancements in adjuvants and delivery systems, and an increase in healthcare spending. The forecast period may see a rise in trends such as the broader application of mrna vaccine technology, concentrated efforts on pediatric immunizations, measures to control seasonal influenza, improved vaccination rates in developing countries, and customized vaccination approaches.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

Which Factors and External Forces Are Driving Demand in the Influenza Vaccines Market?

The growth of the influenza vaccine market is anticipated to be driven by an increase in cases of seasonal flu. Seasonal influenza, a respiratory illness caused by influenza viruses, usually occurs at specific times of the year, mostly during colder months. This trend is attributed to a combination of factors including antigenic drift, susceptibility among the population, environmental conditions, insufficient vaccine distribution, and the absence of all-encompassing vaccination. Influenza vaccines play a crucial role in decreasing instances of seasonal flu by offering immunity against the prevalent virus strains. For instance, in November 2023, the US government agency, the Centers for Disease Control and Prevention (CDC), reported roughly 31 million cases of flu-related illnesses, 14 million associated medical visits, 360,000 hospitalizations due to the flu, and 21,000 flu-related deaths during the 2022-2023 flu season. Hence, the escalating occurrence of influenza seasons is fueling the expansion of the influenza vaccines market.

Which Segments in the Influenza Vaccines Offer the Most Growth?

The influenza vaccines market covered in this report is segmented –

1) By Vaccine Type: Inactivated, Live Attenuated

2) By Valency: Quadrivalent, Trivalent

3) By Route Of Administration: Injection, Nasal Spray

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:

1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)

2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=11935&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Influenza Vaccines Market?# Market?

North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theInfluenza Vaccines Market’s Growth?

The rise in sophisticated vaccine production technology is becoming a pivotal trend in the influenza vaccine industry. Businesses in this sector are increasingly leveraging these advanced processes to maintain their market stance. For example, GlaxoSmithKline PLC., a British pharmaceutical and biotech firm, rolled out a Multi Antigen Presenting System (MAPS) for vaccine creation in January 2023. This cutting-edge approach offers a fresh perspective on generating potent vaccines against bacterial and viral threats. Importantly, this technology accelerates the development of vaccines, proving essential in the event of an epidemic or pandemic outbreak.

View the full report here:

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

What Are the Key Elements That Define the Influenza Vaccines Market?

Influenza vaccines refer to flu vaccines designed to provide immunity against influenza viruses. These are quadrivalent vaccines, designed to protect against four different flu viruses, including two influenza A viruses and two influenza B viruses.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11935

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theInfluenza Vaccines Market?

The influenza vaccine market is set to escalate due to increasing occurrences of seasonal influenza. The term seasonal influenza denotes a respiratory illness brought about by influenza viruses that typically scatter and cause infections during certain periods of the year, primarily in colder months. Contributors to this trend include antigenic drift, susceptibility of populations, environmental factors, incomplete vaccine coverage, and lack of universal vaccination. Influenza vaccines play a crucial role in curbing these seasonal influenza instances by offering immunization against ongoing strains of the virus. For instance, during the flu season of 2022-2023, the Centers for Disease Control and Prevention (CDC), an organization based in the US, disclosed that there were roughly 31 million flu-related illnesses, 14 million flu-related medical visits, 360,000 flu-related hospitalizations, and 21,000 flu-related deaths. Hence, the increasing episodes of influenza seasons are fueling the growth of the influenza vaccines market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

#What is the Anticipated CAGR of theInfluenza Vaccines Market, and What Factors Will Drive It?

The market size of influenza vaccines has seen robust growth in the past few years. It’s projected to expand from $7.35 billion in 2024 to $7.9 billion in 2025, representing a compound annual growth rate (CAGR) of 7.5%. This substantial growth in the previous period is due to factors like preparedness for pandemics, initiatives for public health, studies on vaccine efficacy, healthcare professional advices, and worldwide influenza surveillance.

The market size of influenza vaccines is projected to experience significant expansion in the upcoming years, with potential growth up to $11.02 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. This anticipated growth within the given period can be attributed to a variety of factors such as climate and environmental conditions, improvements in healthcare accessibility, the emergence of new influenza strains, advancements in adjuvants and delivery systems, and an increase in healthcare expenditure. Upcoming trends within this period include the expanded application of mRNA vaccine technology, a concentrated focus on pediatric immunization, measures for seasonal influenza control, improved vaccination coverage in emerging nations, and customized vaccination strategies.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11935

Which Cutting-Edge Market Trends Are Expected to Drive theInfluenza Vaccines Market’s Growth?

The influenza vaccine market is seeing an increase in the popularity of the key trend of utilizing advanced technology for vaccine production. To maintain their market presence, companies engaged in the influenza vaccine market are employing cutting-edge vaccine production technologies. A prime example is GlaxoSmithKline PLC., a pharmaceutical and biotechnology company from the UK, which introduced the Multiple Antigen Presenting System (MAPS) for vaccine development in January 2023. This technology provides a novel approach to developing efficacious vaccines against bacteria and viruses. Crucially, it aids in the quick development of vaccines in the event of an epidemic or pandemic outbreak.

What Are the Leading Market Players Impacting theInfluenza Vaccines Market’s Growth Trend?

Major companies operating in the influenza vaccines market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, Gamma Vaccines Pty. Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

How Are the Key Segments of the Influenza Vaccines Market Driving Opportunities and Innovations?

The influenza vaccines market covered in this report is segmented –

1) By Vaccine Type: Inactivated, Live Attenuated

2) By Valency: Quadrivalent, Trivalent

3) By Route Of Administration: Injection, Nasal Spray

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:

1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)

2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=11935&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theInfluenza Vaccines Market?# Market Expansion?

North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Influenza Vaccines Maret 2025, By The Business Research Company:

Professional Services Global Market Opportunities And Strategies To 2032

https://www.thebusinessresearchcompany.com/report/professional-services-market

Software Products Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/software-products-global-market-report

IoT in Manufacturing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the influenza vaccines market size evolved in recent years?

The market size for influenza vaccines has seen robust growth over the recent years. The growth will escalate from $7.35 billion in 2024 to $7.9 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The expansion in the previous period could be linked to pandemic readiness, initiatives in public health, studies on vaccine effectiveness, recommendations by healthcare professionals, and global surveillance of influenza.

What are the predictions for the influenza vaccines market size in the coming years?

The market for influenza vaccines is predicted to experience significant expansion in the coming years. It’s anticipated to reach $11.02 billion by 2029, with a compound annual growth rate (CAGR) of 8.7%. The projected growth during this period can be linked to several factors including climatic and environmental changes, improvements in healthcare accessibility, the development of new influenza strains, advancements in adjuvants and delivery systems, and increased healthcare spending. Key trends expected during the forecast period involve the broad application of mRNA vaccine technology, emphasis on pediatric immunization, strategies to control seasonal influenza, improved vaccination coverage in emerging economies, and personalized vaccination approaches.

Get your influenza vaccines market report here!

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

What key factors are fueling the growth of the influenza vaccines market?

The influenza vaccine market’s growth is likely to be boosted by an increase in cases of seasonal flu. Seasonal flu is a respiratory disease caused by viruses that usually spread and cause infections at certain times of the year, primarily during colder months. The frequency of these cases is due to various factors such as antigenic drift, vulnerability of the population, environmental factors, gaps in vaccine coverage and the absence of universal vaccination. Influenza vaccines help lessen the occurrence of seasonal flu by providing immunity against the prevalent strains of the virus. For instance, in November 2023, the US-based government agency, Centers for Disease Control and Prevention (CDC), noted that there were about 31 million flu-related illnesses, 14 million medical visits due to the flu, 360,000 hospitalizations from the flu, and 21,000 deaths caused by the flu during the 2022-2023 flu season. Accordingly, the upward trend in the number of influenza seasons has powered the growth of the influenza vaccine market.

How is the global influenza vaccines market divided into key segments?

The influenza vaccines market covered in this report is segmented –

1) By Vaccine Type: Inactivated, Live Attenuated

2) By Valency: Quadrivalent, Trivalent

3) By Route Of Administration: Injection, Nasal Spray

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:

1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)

2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

Who are the key firms paving the way for growth in the influenza vaccines market?

Major companies operating in the influenza vaccines market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, Gamma Vaccines Pty. Ltd.

Which trends are expected to transform the influenza vaccines market?

The adoption of cutting-edge vaccine manufacturing technologies is an emerging trend within the influenza vaccine market. To maintain their market presence, companies within this sector are turning to these advanced technologies for vaccine production. For example, in January 2023, UK-based firm GlaxoSmithKline PLC., operating in biotechnology and pharmaceutical industries, unveiled MAPS, or Multiple Antigen Presenting System, for vaccine creation. This pioneering technique offers a novel approach for crafting potent vaccines to combat bacteria and viruses. The technology proves significantly helpful in expediting vaccine development during an epidemic or pandemic breakout.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11935

What regions are contributing significantly to the growth of the influenza vaccines market?

North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Professional Services Global Market Opportunities And Strategies To 2032

https://www.thebusinessresearchcompany.com/report/professional-services-market

Software Products Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/software-products-global-market-report

IoT in Manufacturing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Opportunities are Expected to Drive the Influenza Vaccines Market’s CAGR Through 2034?

The influenza vaccines market has seen strong growth and is expected to expand from $7.35 billion in 2024 to $7.9 billion in 2025, at a CAGR of 7.5%. Historical growth has been driven by pandemic preparedness measures, public health initiatives, research on vaccine effectiveness, recommendations from healthcare professionals, and global influenza surveillance programs.

The influenza vaccines market is projected to expand significantly, reaching $11.02 billion by 2029 at a CAGR of 8.7%. Key drivers include climate-related and environmental factors, improved healthcare accessibility, emergence of new influenza strains, innovations in adjuvants and vaccine delivery systems, and rising healthcare expenditures. Major trends include increased use of mRNA vaccine technology, a focus on pediatric immunization, seasonal influenza control initiatives, expanded vaccination programs in developing regions, and tailored vaccination strategies.

What Are the Primary Drivers Supporting the Growth of the influenza vaccines Market?

The rising prevalence of seasonal influenza is expected to accelerate the growth of the influenza vaccine market in the future. Seasonal influenza is a respiratory infection caused by influenza viruses that typically circulate during specific times of the year, often in colder months. Factors such as antigenic drift, population susceptibility, environmental conditions, incomplete vaccine coverage, and the absence of universal vaccination contribute to seasonal flu outbreaks. Influenza vaccines play a crucial role in mitigating seasonal influenza by providing immunization against circulating virus strains. For instance, in November 2023, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported that during the 2022-2023 flu season, the United States experienced approximately 31 million flu cases, 14 million flu-related medical visits, 360,000 hospitalizations, and 21,000 deaths. Therefore, the rising incidence of seasonal influenza is fueling the growth of the influenza vaccine market.

Explore Comprehensive Insights Into The Global Influenza Vaccines Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

What Are the Leading Industry Players Dominating the Influenza Vaccines Market?

Major companies operating in the influenza vaccines market include:

• Pfizer Inc._x000D_

• F. Hoffmann-La Roche Ltd._x000D_

• Merck & Co. Inc._x000D_

• Novartis AG_x000D_

• Sanofi-Aventis LLC._x000D_

What Are the Latest Trends Leading to Disruption in the Influenza Vaccines Market?

Technologically advanced vaccine production is gaining traction in the influenza vaccine market. Companies in this market are incorporating advanced vaccine production technologies to maintain their market position. For instance, in January 2023, GlaxoSmithKline PLC, a UK-based pharmaceutical and biotechnology company, introduced the MAPS (Multiple Antigen Presenting System) for vaccine development. This system offers an innovative approach to developing effective vaccines to combat bacteria and viruses, enabling faster production during epidemics or pandemics.

Secure Your Global Influenza Vaccines Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

What Are the Core Categories and Segments in the Influenza Vaccines Market Driving Demand and Growth?

The influenza vaccines market covered in this report is segmented –

1) By Vaccine Type: Inactivated, Live Attenuated

2) By Valency: Quadrivalent, Trivalent

3) By Route Of Administration: Injection, Nasal Spray

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:

1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)

2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

Which Regions Are Significant to the Growth of the Influenza Vaccines Market?

North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Influenza Vaccines Market Classified and Defined in Market Analysis?

Influenza vaccines refer to flu vaccines designed to provide immunity against influenza viruses. These are quadrivalent vaccines, designed to protect against four different flu viruses, including two influenza A viruses and two influenza B viruses.

Browse Through More Similar Reports By The Business Research Company:

Professional Services Global Market Opportunities And Strategies To 2032

https://www.thebusinessresearchcompany.com/report/professional-services-market

Software Products Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/software-products-global-market-report

IoT in Manufacturing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: